


<!DOCTYPE html>
<html lang="en">
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app19.us.archive.org';v.server_ms=203;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include -->  

        <title>Evidence-based care guideline for cytomegalovirus prevention following solid organ transplantation. | National Guideline Clearinghouse</title>

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width">
    <link rel="icon" href="/web/20180712182900im_/https://www.guideline.gov/UI/images/favicon-NGC.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="/web/20180712182900im_/https://www.guideline.gov/UI/images/apple-touch-icon-NGC.png">
    <link rel="icon" type="image/png" href="/web/20180712182900im_/https://www.guideline.gov/UI/images/favicon-NGC-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/web/20180712182900im_/https://www.guideline.gov/UI/images/favicon-NGC-16x16.png" sizes="16x16">
    <link rel="manifest" href="/web/20180712182900/https://www.guideline.gov/UI/images/manifest-NGC.json">
    <link rel="mask-icon" href="/web/20180712182900im_/https://www.guideline.gov/UI/images/safari-pinned-tab-NGC.svg" color="#1d4345">
    <meta name="theme-color" content="#ffffff">
    
<link href="/web/20180712182900cs_/https://www.guideline.gov/cassette.axd/stylesheet/8382974d7bae1577062376dcd37102348398fe04/NGCSiteCSS" type="text/css" rel="stylesheet"/>
<!--[if lt IE 9]>
<link href="/cassette.axd/stylesheet/2188ac5b8507764bb4079068f7a3c8d7ccfba0e7/ieCSS" type="text/css" rel="stylesheet"/>
<![endif]-->



    <script async type="text/javascript" id="_fed_an_ua_tag" src="https://web.archive.org/web/20180712182900js_/https://dap.digitalgov.gov/Universal­-Federated-­Analytics-­Min.js?agency=HHS&amp;subagency=AHRQ"></script>
    </head>
<body class="no-js content-page">
<a href="#main-content" id="skip-nav">Skip to main content</a>
<!--https://developers.google.com/tag-manager/devguide#multidomain  ECH-1199-->
    
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//web.archive.org/web/20180712182900if_/https://www.googletagmanager.com/ns.html?id=GTM-W4NX5V" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712182900/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-W4NX5V');</script>

    <noscript>
        <iframe src="//web.archive.org/web/20180712182900if_/https://www.googletagmanager.com/ns.html?id=GTM-KHDP6Z" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712182900/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-KHDP6Z');</script>
    <!-- End Google Tag Manager -->


    <!-- AHRQ HEADER -->
<div id="ahrq-header">

	<p class="hhs-links">
		<a href="https://web.archive.org/web/20180712182900/http://www.hhs.gov/" target="_blank" class="logo-hhs"><span class="logomark"></span>U.S.&nbsp;Department of&nbsp;Health&nbsp;and Human&nbsp;Services</a>
		<a href="https://web.archive.org/web/20180712182900/http://www.hhs.gov/" target="_blank" class="external-link"><strong>HHS.gov</strong></a>
	</p><!-- /.hhs-links -->
	<p class="ahrq-links">
		<a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/" target="_blank" class="logo-ahrq">Agency for Healthcare Research and Quality: Advancing Excellence in Health Care</a>
		<a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/" target="_blank" class="external-link"><strong>AHRQ.gov</strong></a>
	</p><!-- /.ahrq-links -->

</div><!-- /#ahrq-header -->

	<!-- HEADER -->
	<div class="header" id="header">
		<div class="masthead">

			<ul class="header-actions">
				<li><a href="#header-search" class="search-action"><span class="label">Search</span></a></li>
				<li><a href="#header-account" class="account-action"><span class="label">Account</span></a></li>
				<li><a href="#main-nav" class="menu-action"><span class="label">Menu</span></a></li>
			</ul><!-- /.header-actions -->
				
				<a href="/web/20180712182900/https://www.guideline.gov/" class="header-logo NGC">
				    <picture>
				        <source media="(min-width: 960px)" srcset="/web/20180712182900im_/https://www.guideline.gov/UI/images/logo_NGC_header.png">
				        <source srcset="/web/20180712182900im_/https://www.guideline.gov/UI/images/logo_NGC_header_m.png">
				        <img src="/web/20180712182900im_/https://www.guideline.gov/UI/images/logo_NGC_header.png" alt="National Guideline Clearinghouse">
				    </picture>
				</a>
<form action="/web/20180712182900/https://www.guideline.gov/search" class="header-search header-action" enctype="multipart/form-data" id="header-search" method="get">					<p class="search-bar">
						<label for="q"><span class="screen-reader-text">Search</span>
							<input id="q" type="text" title="Search Input" name="q" class="search-input" placeholder="Search">
						</label>
						<input id="masthead-search-button" type="submit" title="Search Submit" class="search-submit" value="Search">
					</p>
					<p class="search-tips">
						<a href="/web/20180712182900/https://www.guideline.gov/help-and-about/search-browse/search-tips">Search Tips</a>
					</p>
</form>				<div class="header-account header-action" id="header-account">
				<a id="login-button" class="signin" href="/web/20180712182900/https://www.guideline.gov/accounts/signinlanding" aria-role="tab" aria-controls="login-panel" aria-selected="false">Log into My NGC</a>
<div id="login-panel" class="login dropdown" aria-role="tab-panel" aria-labeledby="login-button" aria-hidden="true">
    
            <div class="sign-in">
            <form id="sign-in-form" action="/web/20180712182900/https://www.guideline.gov/Accounts/LoginSubmit" method="post">
                <h3>Sign In</h3>
                <div class="errormessages"></div>
                <p class="invalid-user-cred message-block" style="display: none;"></p>
                <p>
                    <label for="sign-in-username">Username or Email <span class="required">*</span></label>
                    <input type="text" id="sign-in-username" class="input-text" name="email" required>
                   
                </p>
                <p>
                    <label for="sign-in-userpwd">Password <span class="required">*</span></label>
                    <input type="password" id="sign-in-userpwd" class="input-text" name="password" required>
                  
                </p>
                <p class="form-link"><a href="/web/20180712182900/https://www.guideline.gov/accounts/forgotpassword">Forgot Password?</a></p>
                <p><label for="remember-me"><input type="checkbox" name="remember-me" id="remember-me">Remember Me</label></p>
                <input id="account-sign-in" type="submit" value="Sign In"/>
            </form>
            <p>
                <label for="sign-up-btn">Don't have an account?</label>
                <a href="/web/20180712182900/https://www.guideline.gov/accounts/login" class="sign-up-btn" id="sign-up-btn">Create New Account</a>
            </p>
        </div><!--/.sign-in-->
</div><!-- /.login -->
				</div><!-- /.header-account -->
		</div><!-- /.masthead -->

		<div class="main-nav header-action" id="main-nav">
		    <ul class="level-1">
		        <li class=""><a href="/web/20180712182900/https://www.guideline.gov/">Home</a></li>
		        <li class=""><a href="/web/20180712182900/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
		        <li>
<a href="/web/20180712182900/https://www.guideline.gov/summaries/browse" class="parent-link">Guideline Summaries</a>                    		            <ul class="level-2 dropdown">
                             <li class=""><a href="/web/20180712182900/https://www.guideline.gov/browse/clinical-specialty">By Clinical Specialty</a></li>
		                <li class=""><a href="/web/20180712182900/https://www.guideline.gov/browse/organization">By Organization</a></li>
		                <li class=""><a href="/web/20180712182900/https://www.guideline.gov/browse/mesh-tag">By MeSH Tag</a></li>
		                <li class=""><a href="/web/20180712182900/https://www.guideline.gov/summaries/in-progress">In Progress</a></li>
		                <li class=""><a href="/web/20180712182900/https://www.guideline.gov/summaries/archive">Archive</a></li>

		                <li class=""><a href="/web/20180712182900/https://www.guideline.gov/search?f_DocType=0&amp;fLockTerm=Guideline Summaries">All Summaries</a></li>
		            </ul>
		        </li>
<li class=""><a href="/web/20180712182900/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>		        <li class=""><a href="/web/20180712182900/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		        <li class=""><a href="/web/20180712182900/https://www.guideline.gov/matrix">Matrix Tool</a></li>
		        <li class="">
<a href="/web/20180712182900/https://www.guideline.gov/summaries/submit">Submit Guidelines</a>                    		        </li>
                <li class=""><a href="/web/20180712182900/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>		      
		    </ul>
		</div><!-- /.main-nav -->
</div><!-- /.header -->

    <br/><div class="content"><div class="fundingNotice2"><b>The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018</b> because federal funding <br/>through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our <a href="/web/20180712182900/https://www.guideline.gov/home/announcements">full announcement</a>.</div></div>

	<!-- CONTENT -->
	<main id="main-content" tabindex="-1">
		

<div class="main">

		<div class="aside-container">

	<div class="content">

    <!-- CONTENT HEADER -->
    <div class="content-header">
        <ul class="content-header-meta">
            <li class="prefix-icon guideline">Guideline Summary</li>
            <li>NGC:010065</li>
            <li>2001 Jun 7 (revised 2013 Sep 30)
            </li>            
                                </ul>
        <div>
                <h1>Evidence-based care guideline for cytomegalovirus prevention following solid organ transplantation.</h1>
        </div>
    </div>
    <!-- /.content-header-meta -->

        <!-- CONTENT TABS -->
        <ul class="content-tabs">
            <li><a href="#developer-tab" class="developer is-active"><span class="label">Developer</span></a></li>
            <li><a href="#source-tab" class="source"><span class="label">Source</span></a></li>
            <li><a href="#status-tab" class="status"><span class="label">Status</span></a></li>
            <li><a href="#classification-tab" class="classification"><span class="label">Classification</span></a></li>
        </ul>
        <div id="developer-tab" class="is-active content-tab-panel">
                <ul class="developer-list">
        <li><a href="/web/20180712182900/https://www.guideline.gov/search?f_Guideline_Developer_String=Cincinnati%20Children%27s%20Hospital%20Medical%20Center&amp;fLockTerm=Cincinnati%2BChildren%2527s%2BHospital%2BMedical%2BCenter">Cincinnati Children&#39;s Hospital Medical Center</a></li>
                        <li>   
                                <a id="925" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
                </ul>
        </div>
    <!-- /.content-tab-panel -->
    <div id="source-tab" class="content-tab-panel">
<table><tr><td>Cincinnati Children's Hospital Medical Center. Evidence-based clinical care guideline for cytomegalovirus prevention following solid organ transplantation. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2013 Sep 30. 10 p.  [50 references]</td></tr></table>                    <p><a href="/web/20180712182900/https://www.guideline.gov/Home/Disclaimer?id=47380&amp;contentType=fulltextlink&amp;redirect=https%253a%252f%252fwww.cincinnatichildrens.org%252fservice%252fj%252fanderson-center%252fevidence-based-care%252frecommendations%252ftopic">View the original guideline documentation</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712182900im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="status-tab" class="content-tab-panel">
            <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: Cincinnati Children's Hospital Medical Center. Evidence-based care guideline for cytomegalovirus prophylaxis following solid organ transplants. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2007 Jul 6. 15 p. [68 references]</p></div></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="classification-tab" class="content-tab-panel">


        
                    <h4>Age Group</h4>
            <ul>
                        <li><a href="/web/20180712182900/https://www.guideline.gov/search?f_Age_of_Target_Population=Adolescent%20%2813%20to%2018%20years%29&amp;fLockTerm=Adolescent%2B%2813%2Bto%2B18%2Byears%29">Adolescent (13 to 18 years)</a></li>                      
                        <li><a href="/web/20180712182900/https://www.guideline.gov/search?f_Age_of_Target_Population=Adult%20%2819%20to%2044%20years%29&amp;fLockTerm=Adult%2B%2819%2Bto%2B44%2Byears%29">Adult (19 to 44 years)</a></li>                      
                        <li><a href="/web/20180712182900/https://www.guideline.gov/search?f_Age_of_Target_Population=Child%20%282%20to%2012%20years%29&amp;fLockTerm=Child%2B%282%2Bto%2B12%2Byears%29">Child (2 to 12 years)</a></li>                      
                        <li><a href="/web/20180712182900/https://www.guideline.gov/search?f_Age_of_Target_Population=Infant%20%281%20to%2023%20months%29&amp;fLockTerm=Infant%2B%281%2Bto%2B23%2Bmonths%29">Infant (1 to 23 months)</a></li>                      
                        <li><a href="/web/20180712182900/https://www.guideline.gov/search?f_Age_of_Target_Population=Infant%2C%20Newborn%20%28to%201%20month%29&amp;fLockTerm=Infant%252c%2BNewborn%2B%28to%2B1%2Bmonth%29">Infant, Newborn (to 1 month)</a></li>                      
            </ul>
                    <h4>UMLS Concepts <a href="/web/20180712182900/https://www.guideline.gov/help-and-about/search-browse/umls-concepts" class="what-is">(what is this?)</a></h4>
                <div class="field">
                    <h5 class="field-label">ICD9CM</h5>
                    <div class="field-content">
<a href="/web/20180712182900/https://www.guideline.gov/search?f_ICD9CM_CUI=C0010823&amp;fLockTerm=Cytomegaloviral+disease">Cytomegaloviral disease</a>
 (078.5)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MSH</h5>
                    <div class="field-content">
<a href="/web/20180712182900/https://www.guideline.gov/search?f_MSH_CUI=C0003451&amp;fLockTerm=Antiviral+Agents">Antiviral Agents</a>
, <a href="/web/20180712182900/https://www.guideline.gov/search?f_MSH_CUI=C0010823&amp;fLockTerm=Cytomegalovirus+Infections">Cytomegalovirus Infections</a>
, <a href="/web/20180712182900/https://www.guideline.gov/search?f_MSH_CUI=C0017066&amp;fLockTerm=Ganciclovir">Ganciclovir</a>
, <a href="/web/20180712182900/https://www.guideline.gov/search?f_MSH_CUI=C0029216&amp;fLockTerm=Organ+Transplantation">Organ Transplantation</a>
, <a href="/web/20180712182900/https://www.guideline.gov/search?f_MSH_CUI=C0032520&amp;fLockTerm=Polymerase+Chain+Reaction">Polymerase Chain Reaction</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MTH</h5>
                    <div class="field-content">
<a href="/web/20180712182900/https://www.guideline.gov/search?f_MTH_CUI=C0003451&amp;fLockTerm=Antiviral+Agents">Antiviral Agents</a>
, <a href="/web/20180712182900/https://www.guideline.gov/search?f_MTH_CUI=C0010823&amp;fLockTerm=Cytomegalovirus+Infections">Cytomegalovirus Infections</a>
, <a href="/web/20180712182900/https://www.guideline.gov/search?f_MTH_CUI=C0017066&amp;fLockTerm=Ganciclovir">Ganciclovir</a>
, <a href="/web/20180712182900/https://www.guideline.gov/search?f_MTH_CUI=C0029216&amp;fLockTerm=Organ+Transplantation">Organ Transplantation</a>
, <a href="/web/20180712182900/https://www.guideline.gov/search?f_MTH_CUI=C0032520&amp;fLockTerm=Polymerase+Chain+Reaction">Polymerase Chain Reaction</a>
, <a href="/web/20180712182900/https://www.guideline.gov/search?f_MTH_CUI=C0086930&amp;fLockTerm=Risk+Assessment">Risk Assessment</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">PDQ</h5>
                    <div class="field-content">
<a href="/web/20180712182900/https://www.guideline.gov/search?f_PDQ_CUI=C0017066&amp;fLockTerm=ganciclovir">ganciclovir</a>
, <a href="/web/20180712182900/https://www.guideline.gov/search?f_PDQ_CUI=C0029216&amp;fLockTerm=organ+transplantation">organ transplantation</a>
, <a href="/web/20180712182900/https://www.guideline.gov/search?f_PDQ_CUI=C0032520&amp;fLockTerm=polymerase+chain+reaction">polymerase chain reaction</a>
, <a href="/web/20180712182900/https://www.guideline.gov/search?f_PDQ_CUI=C0909381&amp;fLockTerm=valganciclovir">valganciclovir</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SNOMEDCT_US</h5>
                    <div class="field-content">
<a href="/web/20180712182900/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0003451&amp;fLockTerm=Antiviral+agent">Antiviral agent</a>
 (32249005), <a href="/web/20180712182900/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0003451&amp;fLockTerm=Antiviral+agent">Antiviral agent</a>
 (372701006), <a href="/web/20180712182900/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0010823&amp;fLockTerm=Cytomegalovirus+infection">Cytomegalovirus infection</a>
 (28944009), <a href="/web/20180712182900/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0017066&amp;fLockTerm=Ganciclovir">Ganciclovir</a>
 (372848001), <a href="/web/20180712182900/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0017066&amp;fLockTerm=Ganciclovir">Ganciclovir</a>
 (78025001), <a href="/web/20180712182900/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032520&amp;fLockTerm=Polymerase+chain+reaction">Polymerase chain reaction</a>
 (258066000), <a href="/web/20180712182900/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0086930&amp;fLockTerm=Risk+assessment">Risk assessment</a>
 (225338004), <a href="/web/20180712182900/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0909381&amp;fLockTerm=Valganciclovir">Valganciclovir</a>
 (129476000), <a href="/web/20180712182900/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0909381&amp;fLockTerm=Valganciclovir">Valganciclovir</a>
 (395266000)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
    </div>
        <!-- /.content-tab-panel -->
        <!-- /.content-tab-panel -->
        <!-- TOOLBAR -->
        <div class="content-toolbar">

            <!-- Primary -->
            <ul class="tools primary-tools">
                <li class="dropdown tool sections">
                    <a href="#" class="tool-button">Sections</a>
                    <div class="dropdown-panel">
                            <ul class="section-links">
                                    <li><a href="#420" class="section-mark">Recommendations</a></li>
                                    <li><a href="#396" class="section-mark">Scope</a></li>
                                    <li><a href="#405" class="section-mark">Methodology</a></li>
                                    <li><a href="#424" class="section-mark">Evidence Supporting the Recommendations</a></li>
                                    <li><a href="#427" class="section-mark">Benefits/Harms of Implementing the Guideline Recommendations</a></li>
                                    <li><a href="#432" class="section-mark">Qualifying Statements</a></li>
                                    <li><a href="#434" class="section-mark">Implementation of the Guideline</a></li>
                                    <li><a href="#439" class="section-mark">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></li>
                                    <li><a href="#442" class="section-mark">Identifying Information and Availability</a></li>
                                    <li><a href="#99999" class="section-mark">Disclaimer</a></li>
                            </ul>    
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
            </ul>

            <!-- Other -->
            <ul class="tools other-tools">
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Download</a>

                    <div class="dropdown-panel">
                        <ul>
                            <li><a href="/web/20180712182900/https://www.guideline.gov/summaries/downloadcontent/ngc-10065?contentType=pdf" class="pdf">.PDF 105.1 kb</a></li>
                            <li><a href="/web/20180712182900/https://www.guideline.gov/summaries/downloadcontent/ngc-10065?contentType=word" class="word">Word Document 296.1 kb</a></li>
                            <li><a href="/web/20180712182900/https://www.guideline.gov/summaries/downloadcontent/ngc-10065?contentType=xml" class="xml">.XML 45.3 kb</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Share</a>
                    <div class="dropdown-panel">
                        <ul class="toolbar-social">
                            <li><a target="_blank" href="https://web.archive.org/web/20180712182900/https://www.facebook.com/sharer/sharer.php?u=https://www.guideline.gov/summaries/summary/47380/evidencebased-care-guideline-for-cytomegalovirus-prevention-following-solid-organ-transplantation" class="facebook">Facebook</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712182900/https://twitter.com/share?text=&amp;url=https://www.guideline.gov/summaries/summary/47380/evidencebased-care-guideline-for-cytomegalovirus-prevention-following-solid-organ-transplantation" class="twitter">Twitter</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712182900/https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.guideline.gov/summaries/summary/47380/evidencebased-care-guideline-for-cytomegalovirus-prevention-following-solid-organ-transplantation&amp;title=&amp;summary=&amp;source=" class="linkedin">Linkedin</a></li>
                            <li><a href="https://web.archive.org/web/20180712182900/mailto:/?Subject=AHRQ: Evidence-based care guideline for cytomegalovirus prevention following solid organ transplantation.&amp;body=https://www.guideline.gov/summaries/summary/47380/evidencebased-care-guideline-for-cytomegalovirus-prevention-following-solid-organ-transplantation" class="email">Email</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Cite</a>
                    <div class="dropdown-panel citation">
                        <p class="text-label"><label for="citation">Citation: </label></p>
                        <textarea id="citation">National Guideline Clearinghouse (NGC). Guideline summary: Evidence-based care guideline for cytomegalovirus prevention following solid organ transplantation. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2013 Sep 30. [cited 2018 Jul 12]. Available: https://www.guideline.gov</textarea>                        
                        <p class="text-label">Download citation file: </p>
                        <ul>
                            <li><a href="/web/20180712182900/https://www.guideline.gov/summaries/citedownload/47380?format=ris">RIS (Zotero)</a></li>
                            <li><a href="/web/20180712182900/https://www.guideline.gov/summaries/citedownload/47380?format=enw">EndNote</a></li>
                            <li><a href="/web/20180712182900/https://www.guideline.gov/summaries/citedownload/47380?format=bibtex">BibTex</a></li>
                            <li><a href="/web/20180712182900/https://www.guideline.gov/summaries/citedownload/47380?format=txt">Medlars</a></li>
                            <li><a href="/web/20180712182900/https://www.guideline.gov/summaries/citedownload/47380?format=ris">ProCite</a></li>
                            <li><a href="/web/20180712182900/https://www.guideline.gov/summaries/citedownload/47380">RefWorks</a></li>
                            <li><a href="/web/20180712182900/https://www.guideline.gov/summaries/citedownload/47380?format=ris">Reference Manager</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                                
                <li class="tool">
                        <a href="#" id="47380" data-alert="SignInLanding" class="tool-button save-link">Save</a>
                </li>
            </ul>

            <!-- Accordion -->
            <ul class="tools accordion-controls">
                <li class="tool"><a href="#" class="expand-all is-disabled" aria-disabled="true"><span class="screen-reader-text">Expand All</span></a></li>
                <li class="tool"><a href="#" class="collapse-all" aria-disabled="false"><span class="screen-reader-text">Collapse All</span></a></li>
            </ul>
        </div>
        <!-- /.toolbar -->


		<!-- ARTICLE -->
		<div class="article" id="article">
			




    <!-- ACCORDION -->
    <div class="accordion-container" role="tablist" multiselectable="true">
                <h2 id="420" class="accordion-title section-420 is-active" role="tab" aria-expanded="true"><a href="#">Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Major Recommendations</a></h3>
                    <p><div class="content_para"><p>The strength of the recommendation (strongly recommended, recommended, or no recommendation) and the quality of the evidence (1a‒5b) are defined at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Assessment</span></strong></p>
<p><strong>Laboratory Assessment/Monitoring</strong></p>
<ol style="list-style-type: decimal;" start="1">
    <li>It is recommended:
    <ul style="list-style-type: disc;">
        <li>That whole blood cytomegalovirus (CMV) deoxyribonucleic acid (DNA) polymerase chain reaction (PCR) be used for monitoring (Lisboa et al., 2011 [4b (diagnosis)]), and </li>
        <li>That monitoring occur at specified intervals (see Table 2 in original guideline document) (Local Consensus, 2013 [5]). </li>
    </ul>
    </li>
    <li>It is recommended, to assure consistent results, that the same laboratory facility and assay be used for serial samples (Local Consensus, 2013 [5]; Pang et al., 2009 [5a (diagnostics)])
    <p><strong>Note 1</strong>: The laboratory facility at Cincinnati Children's Hospital Medical Center (CCHMC) will be used for CCHMC patients.</p>
    <p><strong>Note 2</strong>: Inconsistent test results may be the result of testing being performed:</p>
    <ul style="list-style-type: disc;">
        <li>At different laboratory facilities </li>
        <li>Using different assays </li>
        <li>On a different specimen type (e.g., whole blood vs. plasma) (Lisboa et al., 2011 [4b (diagnosis)]) </li>
    </ul>
    <p>Contributing factors may be:</p>
    <ul style="list-style-type: disc;">
        <li>Patient use of different laboratory facility due to geographic need or insurance </li>
        <li>The designated laboratory facility transitions to use a different assay </li>
        <li>Unreliable implementation processes (see the "Description of Implementation Strategy" field and Appendix 2 in the original guideline document) </li>
    </ul>
    </li>
</ol>
<p><strong>Clinical Assessment</strong></p>
<ol style="list-style-type: decimal;" start="3">
    <li>It is recommended that patients with any of the following clinical conditions be evaluated for CMV by examination, whole blood PCR and end-organ histopathology if indicated (Local Consensus, 2013 [5]; Kotton et al., 2013 [5a]):
    <ul style="list-style-type: disc;">
        <li>Fever </li>
        <li>Hepatitis </li>
        <li>Muscle pain </li>
        <li>Gastroenteropathy </li>
        <li>Leukopenia </li>
        <li>Pneumonitis </li>
        <li>Thrombocytopenia </li>
        <li>Retinitis </li>
        <li>Anemia </li>
    </ul>
    </li>
</ol>
<p><strong><span style="text-decoration: underline;">Management Recommendations</span></strong></p>
<p><strong>General</strong></p>
<p>Recommendations for CMV disease prevention in solid organ transplant recipients are based on the organ transplanted and previously defined risk levels (see Table 2 in original guideline document).</p>
<p><strong>Primary Strategy</strong></p>
<ol style="list-style-type: decimal;" start="4">
    <li>It is recommended that <strong>targeted prophylaxis</strong> be the primary strategy for prevention of CMV disease at CCHMC (Local Consensus, 2013 [5]). See the definition for "targeted prophylaxis" on Page 1 of the original guideline document. </li>
</ol>
<p><strong>Risk Stratification</strong></p>
<ol style="list-style-type: decimal;" start="5">
    <li>It is recommended that targeted prophylaxis be risk stratified based on donor/recipient (D/R) CMV serostatus (see Table 2 in the original guideline document) (Local Consensus, 2013 [5], Kotton et al., 2013 [5a]). </li>
    <li>It is recommended to assign infants &lt;12 months of age to the high risk category unless D-/R-, as serology in infants &lt;12 months of age may be confounded by maternal antibody (see Table 3 in the original guideline document) (Local Consensus, 2013 [5]; Kotton et al., 2013 [5a]). </li>
</ol>
<p><strong>Medications</strong></p>
<ol style="list-style-type: decimal;" start="7">
    <li>It is recommended to use age- and weight-based antiviral dosing (see Table 4 in the original guideline document) (Villeneuve et al., 2013 [3a (treatment)]; Launay et al., 2012 [3a (treatment)]; Pescovitz et al., 2010 [3a (treatment)]; Vaudry et al., 2009 [3a (treatment)]; Local Consensus, 2013 [5]). </li>
    <li>It is recommended that valganciclovir (VGCV) be dosed around a meal (Villeneuve et al., 2013 [3a (treatment)]; Pescovitz et al., 2010 [3a (treatment)]). </li>
</ol>
<p><strong><span style="text-decoration: underline;">Definitions</span></strong>:</p>
<p><strong>Table of Evidence Levels</strong></p>
<table border="1" cellspacing="1" cellpadding="3" summary="Table of Evidence Levels">
    <thead>
        <tr>
            <th valign="top" scope="col">Quality Level</th>
            <th valign="top" scope="col">Definition</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top" scope="row">1a&dagger; or 1b&dagger;</td>
            <td valign="top">Systematic review, meta-analysis, or meta-synthesis of multiple studies</td>
        </tr>
        <tr>
            <td valign="top" scope="row">2a or 2b </td>
            <td valign="top">Best study design for domain</td>
        </tr>
        <tr>
            <td valign="top" scope="row">3a or 3b </td>
            <td valign="top">Fair study design for domain</td>
        </tr>
        <tr>
            <td valign="top" scope="row">4a or 4b </td>
            <td valign="top">Weak study design for domain </td>
        </tr>
        <tr>
            <td valign="top" scope="row">5, 5a or 5b </td>
            <td valign="top">Other: General review, expert opinion, case report, consensus report, or guideline&nbsp;</td>
        </tr>
    </tbody>
</table>
<p class="Note">&dagger;a = good quality study; b = lesser quality study</p>
<p><strong>Table of Recommendation Strength</strong></p>
<table border="1" cellspacing="1" cellpadding="3" summary="Table of Recommendation Strength">
    <thead>
        <tr>
            <th valign="top">Strength</th>
            <th valign="top">Definition</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">"Strongly Recommended"</td>
            <td valign="top">There is consensus that benefits clearly outweigh risks and burdens (or vice versa for negative recommendations).</td>
        </tr>
        <tr>
            <td valign="top">"Recommended"</td>
            <td valign="top">There is consensus that benefits are closely balanced with risks and burdens.</td>
        </tr>
        <tr>
            <td valign="top">No recommendation made</td>
            <td valign="top">There is lack of consensus to direct development of a recommendation.</td>
        </tr>
    </tbody>
</table>
<p class="Note"><strong>Note</strong>: See the original guideline document for the dimensions used for judging the strength of the recommendation.</p></div></p>
                        <h3><a href="#">Clinical Algorithm(s)</a></h3>
                    <p><div class="content_para"><p>None provided</p></div></p>

            </div>
                <h2 id="396" class="accordion-title section-396 is-active" role="tab" aria-expanded="true"><a href="#">Scope</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Disease/Condition(s)</a></h3>
                    <p><div class="content_para"><p>Cytomegalovirus (CMV) infection and disease following solid organ transplants</p></div></p>
                        <h3><a href="#">Guideline Category</a></h3>
                    <p>Evaluation</p>
                    <p>Management</p>
                    <p>Prevention</p>
                    <p>Risk Assessment</p>
                        <h3><a href="#">Clinical Specialty</a></h3>
                    <p>Cardiology</p>
                    <p>Critical Care</p>
                    <p>Gastroenterology</p>
                    <p>Hematology</p>
                    <p>Infectious Diseases</p>
                    <p>Internal Medicine</p>
                    <p>Nephrology</p>
                    <p>Pathology</p>
                    <p>Pediatrics</p>
                    <p>Preventive Medicine</p>
                    <p>Pulmonary Medicine</p>
                    <p>Surgery</p>
                        <h3><a href="#">Intended Users</a></h3>
                    <p>Advanced Practice Nurses</p>
                    <p>Nurses</p>
                    <p>Patients</p>
                    <p>Pharmacists</p>
                    <p>Physician Assistants</p>
                    <p>Physicians</p>
                        <h3><a href="#">Guideline Objective(s)</a></h3>
                    <p><div class="content_para"><p>To prevent cytomegalovirus (CMV) disease in at-risk solid organ transplant recipients through risk stratification and targeted and cost-effective prevention strategies</p></div></p>
                        <h3><a href="#">Target Population</a></h3>
                    <p><div class="content_para"><p>Patients with solid organ transplant, ages birth to young adults</p>
<p class="Note"><strong>Note</strong>: These recommendations are NOT intended for use in the following:</p>
<ul class="contentListFont">
    <li>Patients with cytomegalovirus (CMV) disease </li>
    <li>Patients with non-solid organ transplants </li>
</ul></div></p>
                        <h3><a href="#">Interventions and Practices Considered</a></h3>
                    <p><div class="content_para"><p><strong>Evaluation/Risk Assessment</strong></p>
<ol style="list-style-type: decimal;" start="1">
    <li>Use of whole blood cytomegalovirus (CMV) deoxyribonucleic acid (DNA) polymerase chain reaction (PCR) for monitoring at specified intervals </li>
    <li>Using the same laboratory facility and assay for serial samples </li>
    <li>Clinical assessment of patients if certain conditions indicate </li>
</ol>
<p><strong>Prevention/Management</strong></p>
<ol style="list-style-type: decimal;">
    <li>Targeted prophylaxis with risk stratification based on donor/recipient CMV serostatus </li>
    <li>Age- and weight-based antiviral dosing </li>
    <li>Prophylactic antiviral therapy:
    <ul style="list-style-type: disc;">
        <li>Ganciclovir </li>
        <li>Valganciclovir (VGCV) </li>
    </ul>
    </li>
</ol></div></p>
                        <h3><a href="#">Major Outcomes Considered</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Risk for cytomegalovirus (CMV) infection </li>
    <li>Consistency of laboratory assays for CMV </li>
    <li>Epidemiology of CMV by organ type </li>
    <li>Incidence of CMV infection following prophylactic therapy </li>
    <li>Adverse effects of prophylactic therapy </li>
</ul></p>

            </div>
                <h2 id="405" class="accordion-title section-405 is-active" role="tab" aria-expanded="true"><a href="#">Methodology</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Methods Used to Collect/Select the Evidence</a></h3>
                    <p>Searches of Electronic Databases</p>
                        <h3><a href="#">Description of Methods Used to Collect/Select the Evidence</a></h3>
                    <p><div class="content_para"><p>To select evidence for critical appraisal by the group for this guideline, the MEDLINE, EMBASE and the Cochrane databases were searched for dates of January 2007 to August 2013 to generate an unrefined, "combined evidence" database using a search strategy focused on answering clinical questions relevant to cytomegalovirus and solid organ transplantation and employing a combination of Boolean searching on human-indexed thesaurus terms (MeSH headings using an OVID MEDLINE interface) and "natural language" searching on words in the title, abstract, and indexing terms. The citations were reduced by: eliminating duplicates, review articles, and non-English articles. The resulting abstracts were reviewed to eliminate low quality and irrelevant citations. During the course of the guideline development, additional clinical questions were generated and subjected to the search process. January 2007 was the last date for which literature was reviewed for the previous version of this guideline. All previous citations were reviewed for appropriateness to this revision.</p></div></p>
                        <h3><a href="#">Number of Source Documents</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Methods Used to Assess the Quality and Strength of the Evidence</a></h3>
                    <p>Weighting According to a Rating Scheme (Scheme Given)</p>
                        <h3><a href="#">Rating Scheme for the Strength of the Evidence</a></h3>
                    <p><div class="content_para"><p><strong>Table of Evidence Levels</strong></p>
<table border="1" cellspacing="1" cellpadding="3" summary="Table of Evidence Levels">
    <thead>
        <tr>
            <th valign="top" scope="col">Quality Level</th>
            <th valign="top" scope="col">Definition</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top" scope="row">1a&dagger; or 1b&dagger;</td>
            <td valign="top">Systematic review, meta-analysis, or meta-synthesis of multiple studies</td>
        </tr>
        <tr>
            <td valign="top" scope="row">2a or 2b </td>
            <td valign="top">Best study design for domain</td>
        </tr>
        <tr>
            <td valign="top" scope="row">3a or 3b </td>
            <td valign="top">Fair study design for domain</td>
        </tr>
        <tr>
            <td valign="top" scope="row">4a or 4b </td>
            <td valign="top">Weak study design for domain </td>
        </tr>
        <tr>
            <td valign="top" scope="row">5, 5a or 5b </td>
            <td valign="top">Other: General review, expert opinion, case report, consensus report, or guideline </td>
        </tr>
    </tbody>
</table>
<p class="Note">&dagger;a = good quality study; b = lesser quality study</p></div></p>
                        <h3><a href="#">Methods Used to Analyze the Evidence</a></h3>
                    <p>Systematic Review</p>
                        <h3><a href="#">Description of the Methods Used to Analyze the Evidence</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Methods Used to Formulate the Recommendations</a></h3>
                    <p>Expert Consensus</p>
                        <h3><a href="#">Description of Methods Used to Formulate the Recommendations</a></h3>
                    <p><div class="content_para"><p>The process by which this guideline was developed is documented in the Guideline Development Process Manual (see the "Availability of Companion Documents" field); relevant development materials are kept electronically. The recommendations contained in this guideline were formulated by an interdisciplinary working group which performed systematic search and critical appraisal of the literature, using the Table of Evidence Levels (see the "Rating Scheme for the Strength of the Evidence field"), and examined current local clinical practices.</p>
<p>Recommendations have been formulated by a consensus process directed by best evidence, patient and family preference and clinical expertise. During formulation of these recommendations, the team members have remained cognizant of controversies and disagreements over the management of these patients. The team&nbsp;tried to resolve controversial issues by consensus where possible and, when not possible, to offer optional approaches to care in the form of information that includes best supporting evidence of efficacy for alternative choices.</p></div></p>
                        <h3><a href="#">Rating Scheme for the Strength of the Recommendations</a></h3>
                    <p><div class="content_para"><p><strong>Table of Recommendation Strength</strong></p>
<table border="1" cellspacing="1" cellpadding="3" summary="Table of Recommendation Strength">
    <thead>
        <tr>
            <th valign="top">Strength</th>
            <th valign="top">Definition</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">"Strongly Recommended"</td>
            <td valign="top">There is consensus that benefits clearly outweigh risks and burdens (or vice versa for negative recommendations).</td>
        </tr>
        <tr>
            <td valign="top">"Recommended"</td>
            <td valign="top">There is consensus that benefits are closely balanced with risks and burdens.</td>
        </tr>
        <tr>
            <td valign="top">No recommendation made</td>
            <td valign="top">There is lack of consensus to direct development of a recommendation.</td>
        </tr>
    </tbody>
</table>
<p class="Note"><strong>Note</strong>: See the original guideline document for the dimensions used for judging the strength of the recommendation.</p></div></p>
                        <h3><a href="#">Cost Analysis</a></h3>
                    <p><div class="content_para"><p>A formal cost analysis was not performed and published cost analyses were not reviewed.</p></div></p>
                        <h3><a href="#">Method of Guideline Validation</a></h3>
                    <p>Internal Peer Review</p>
                        <h3><a href="#">Description of Method of Guideline Validation</a></h3>
                    <p><div class="content_para"><p>The recommendations have been reviewed and approved by clinical experts not involved in the development process and distributed to other parties as appropriate to their intended purposes.</p></div></p>

            </div>
                <h2 id="424" class="accordion-title section-424 is-active" role="tab" aria-expanded="true"><a href="#">Evidence Supporting the Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">References Supporting the Recommendations</a></h3>
                    <p><table><tr><td>Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov L, Humar A, Transplantation Society International CMV Consensus Group. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2013 Aug 27;96(4):333-60. <a href="https://web.archive.org/web/20180712182900/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=23896556" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180712182900im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Launay E, Theoret Y, Litalien C, Duval M, Alvarez F, Lapeyraque AL, Phan V, Larocque D, Poirier N, Lamarre V, Ovetchkine P. Pharmacokinetic profile of valganciclovir in pediatric transplant recipients. Pediatr Infect Dis J. 2012 Apr;31(4):405-7. <a href="https://web.archive.org/web/20180712182900/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22198827" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180712182900im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Lisboa LF, Asberg A, Kumar D, Pang X, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Humar A. The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response. Transplantation. 2011 Jan 27;91(2):231-6. <a href="https://web.archive.org/web/20180712182900/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=21048530" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180712182900im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Pang XL, Fox JD, Fenton JM, Miller GG, Caliendo AM, Preiksaitis JK, American Society of Transplantation Infectious Diseases Community of Practice, Canadian Society of Transplantation. Interlaboratory comparison of cytomegalovirus viral load assays. Am J Transplant. 2009 Feb;9(2):258-68. <a href="https://web.archive.org/web/20180712182900/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19178413" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180712182900im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Pescovitz MD, Ettenger RB, Strife CF, Sherbotie JR, Thomas SE, McDiarmid S, Bartosh S, Ives J, Bouw MR, Bucuvalas J. Pharmacokinetics of oral valganciclovir solution and intravenous ganciclovir in pediatric renal and liver transplant recipients. Transpl Infect Dis. 2010 Jun;12(3):195-203. <a href="https://web.archive.org/web/20180712182900/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=20002356" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180712182900im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Vaudry W, Ettenger R, Jara P, Varela-Fascinetto G, Bouw MR, Ives J, Walker R, Valcyte WV16726 Study Group. Valganciclovir dosing according to body surface area and renal function in pediatric solid organ transplant recipients. Am J Transplant. 2009 Mar;9(3):636-43. <a href="https://web.archive.org/web/20180712182900/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19260840" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180712182900im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Villeneuve D, Brothers A, Harvey E, Kemna M, Law Y, Nemeth T, Gantt S. Valganciclovir dosing using area under the curve calculations in pediatric solid  organ transplant recipients. Pediatr Transplant. 2013 Feb;17(1):80-5. <a href="https://web.archive.org/web/20180712182900/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=23240598" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180712182900im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                        <h3><a href="#">Type of Evidence Supporting the Recommendations</a></h3>
                    <p><div class="content_para"><p>The type of supporting evidence is identified and graded for each recommendation (see the "Major Recommendations" field).</p></div></p>

            </div>
                <h2 id="427" class="accordion-title section-427 is-active" role="tab" aria-expanded="true"><a href="#">Benefits/Harms of Implementing the Guideline Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Potential Benefits</a></h3>
                    <p><div class="content_para"><p>Prevention or decreased incidence of cytomegalovirus (CMV) infection and cytomegalovirus disease and its associated significant morbidity and mortality after solid organ transplantation</p></div></p>
                        <h3><a href="#">Potential Harms</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Valganciclovir (VGCV) and ganciclovir toxicity includes neutropenia, thrombocytopenia, and renal dysfunction require regular monitoring. </li>
    <li>Use caution with VGCV in patients with small bowel transplants due to concerns for malabsorption. </li>
</ul></p>

            </div>
                <h2 id="432" class="accordion-title section-432 is-active" role="tab" aria-expanded="true"><a href="#">Qualifying Statements</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Qualifying Statements</a></h3>
                    <p><div class="content_para"><p>These recommendations result from review of literature and practices current at the time of their formulations. This guideline does not preclude using care modalities proven efficacious in studies published subsequent to the current revision of this document. This document is not intended to impose standards of care preventing selective variances from the guidelines to meet the specific and unique requirements of individual patients. Adherence to this guideline is voluntary. The clinician in light of the individual circumstances presented by the patient must make the ultimate judgment regarding the priority of any specific procedure.</p></div></p>

            </div>
                <h2 id="434" class="accordion-title section-434 is-active" role="tab" aria-expanded="true"><a href="#">Implementation of the Guideline</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Description of Implementation Strategy</a></h3>
                    <p><div class="content_para"><p><strong>Implementation Issues for Cytomegalovirus (CMV) Monitoring Related to External Laboratory Facility Use</strong></p>
<p>Attempts to implement Recommendation #2 may encounter difficulties when use of external laboratory facilities cannot be avoided. Under such circumstances, a reliable process to document the following relevant details will enable appropriate interpretation of assay results.</p>
<p>Specifics to be documented for each specimen:</p>
<ol style="list-style-type: decimal;" start="1">
    <li>Laboratory facility </li>
    <li>Specimen type (whole blood or plasma) </li>
    <li>Unit of measure for results (copies/mL, IU/mL, etc.) </li>
    <li>Assay used (if available) </li>
</ol>
<p>In addition, implementation of this interpretation requires reliable access to these details within the context of clinic flow.</p></div></p>
                        <h3><a href="#">Implementation Tools</a></h3>
                    <p>Patient Resources</p>
                    <p><div class="general-block">For information about availability, see the <i>Availability of Companion Documents</i> and <i>Patient Resources</i> fields below.</div></p>

            </div>
                <h2 id="439" class="accordion-title section-439 is-active" role="tab" aria-expanded="true"><a href="#">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">IOM Care Need</a></h3>
                    <p>Living with Illness</p>
                    <p>Staying Healthy</p>
                        <h3><a href="#">IOM Domain</a></h3>
                    <p>Effectiveness</p>
                    <p>Patient-centeredness</p>

            </div>
                <h2 id="442" class="accordion-title section-442 is-active" role="tab" aria-expanded="true"><a href="#">Identifying Information and Availability</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Bibliographic Source(s)</a></h3>
                    <p><table><tr><td>Cincinnati Children's Hospital Medical Center. Evidence-based clinical care guideline for cytomegalovirus prevention following solid organ transplantation. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2013 Sep 30. 10 p.  [50 references]</td></tr></table></p>
                        <h3><a href="#">Adaptation</a></h3>
                    <p><div class="content_para"><p>Not applicable: The guideline was not adapted from another source.</p></div></p>
                        <h3><a href="#">Date Released</a></h3>
                    <p>2001 Jun 7 (revised 2013 Sep 30)</p>
                        <h3><a href="#">Guideline Developer(s)</a></h3>
                    <p>Cincinnati Children's Hospital Medical Center - Hospital/Medical Center</p>
                        <h3><a href="#">Source(s) of Funding</a></h3>
                    <p><div class="content_para"><p>Cincinnati Children's Hospital Medical Center</p>
<p>The guideline was developed without external funding.</p></div></p>
                        <h3><a href="#">Guideline Committee</a></h3>
                    <p><div class="content_para"><p>Cytomegalovirus (CMV) Prevention following Solid Organ Transplantation Team 2013</p></div></p>
                        <h3><a href="#">Composition of Group That Authored the Guideline</a></h3>
                    <p><div class="content_para"><p><em>Cincinnati Children's Hospital Medical Center Physicians</em>: Lara Danziger-Isakov, MD, MPH, Infectious Diseases (<em>Chair</em>); John Bucuvalas, MD, Liver Transplant; Rohit Kohli, MD, Liver Transplant; Chesney Castleberry, MD, Cardiology/Transplant; Samuel Kocoshis, MD Intestinal Transplant; Jens Goebel, MD, Nephrology/Transplant; Marc Schechter, MD, Pulmonary/Transplant; David Witte, MD, Pathology</p>
<p><em>Patient Services</em>: Trina Hemmelgarn, Pharmacy, PharmD; Danielle Lazear, Pharmacy, PharmD</p>
<p><em>Other Team Members</em>: Michael Lake, Transplant Analytics, MA</p>
<p><em>Professional Support Staff</em>: Eloise Clark, MPH, MBA, Methodologist, James M. Anderson Center for Health Systems Excellence; Scott Wansley, Transplant Administration, MBA</p></div></p>
                        <h3><a href="#">Financial Disclosures/Conflicts of Interest</a></h3>
                    <p><div class="content_para"><p>All Team Members and Clinical Effectiveness support staff listed have declared whether they have any conflict of interest and none were identified. Conflict of interest declaration forms are on file with the Evidence group of the James M. Anderson Center for Health Systems Excellence.</p></div></p>
                        <h3><a href="#">Guideline Status</a></h3>
                    <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: Cincinnati Children's Hospital Medical Center. Evidence-based care guideline for cytomegalovirus prophylaxis following solid organ transplants. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2007 Jul 6. 15 p. [68 references]</p></div></p>
                        <h3><a href="#">Guideline Availability</a></h3>
                    <p><div class="content_para"><p>Available from the <a href="/web/20180712182900/https://www.guideline.gov/Home/Disclaimer?id=47380&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.cincinnatichildrens.org%2fservice%2fj%2fanderson-center%2fevidence-based-care%2frecommendations%2ftopic" title="Cincinnati Children's Hospital Medical Web site">Cincinnati Children's Hospital Medical Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712182900im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p></div></p>
                        <h3><a href="#">Availability of Companion Documents</a></h3>
                    <p><div class="content_para"><p>The following are available:</p>
<ul style="list-style-type: disc;">
    <li>Evidence-based care guideline development and update process. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2006 Mar. 35 p. Available from the <a href="/web/20180712182900/https://www.guideline.gov/Home/Disclaimer?id=47380&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.cincinnatichildrens.org%2f-%2fmedia%2fcincinnati%2520childrens%2fhome%2fservice%2fj%2fanderson-center%2fevidence-based-care%2flegend%2fguideline%2520development%2520manual.pdf%3fla%3den" title="Cincinnati Children's Hospital Medical Center Web site">Cincinnati Children's Hospital Medical Center Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712182900im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>Judging the strength of a recommendation. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2008 Jan. 1 p. Available from the <a href="/web/20180712182900/https://www.guideline.gov/Home/Disclaimer?id=47380&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.cincinnatichildrens.org%2f-%2fmedia%2fcincinnati%2520childrens%2fhome%2fservice%2fj%2fanderson-center%2fevidence-based-care%2flegend%2fjudgingrecommendationstrength%2520717.pdf%3fla%3den" title="Cincinnati Children's Hospital Medical Center">Cincinnati Children's Hospital Medical Center</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712182900im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>Grading a body of evidence to answer a clinical question. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 1 p. </li>
    <li>Table of evidence levels. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2008 Feb 29. 1 p. Available from the <a href="/web/20180712182900/https://www.guideline.gov/Home/Disclaimer?id=47380&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.cincinnatichildrens.org%2f-%2fmedia%2fcincinnati%2520childrens%2fhome%2fservice%2fj%2fanderson-center%2fevidence-based-care%2flegend%2ftable%2520of%2520evidence%2520levels%2520-%2520legend.pdf%3fla%3den" title="Cincinnati Children's Hospital Medical Center">Cincinnati Children's Hospital Medical Center</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712182900im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
</ul></div></p>
                        <h3><a href="#">Patient Resources</a></h3>
                    <p><div class="content_para"><p>The following are available:</p>
<ul style="list-style-type: disc;">
    <li>Medications to prevent infection following kidney transplant. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2012 Dec. Electronic copies: Available from the <a href="/web/20180712182900/https://www.guideline.gov/Home/Disclaimer?id=47380&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.cincinnatichildrens.org%2fhealth%2fk%2finfections%2f" title="Cincinnati Children's Hospital Medical Center (CCHMC) Web site">Cincinnati Children's Hospital Medical Center (CCHMC) Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712182900im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>Cytomegalovirus (CMV) in the immunocompromised patient. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2013 Jul. Electronic copies: Available from the <a href="/web/20180712182900/https://www.guideline.gov/Home/Disclaimer?id=47380&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.cincinnatichildrens.org%2fhealth%2fc%2fcmv-immuno%2f" title="CCHMC Web site">CCHMC Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712182900im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
</ul>
<p class="Disclaimer">Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.</p></div></p>
                        <h3><a href="#">NGC Status</a></h3>
                    <p><div class="content_para"><p>This NGC summary was completed by ECRI on March 11, 2004. This NGC summary was updated by ECRI Institute on February 26, 2008. This summary was updated by ECRI Institute on October 5, 2010 following the U.S. Food and Drug Administration (FDA) advisory on valcyte (valganciclovir hydrochloride). This summary was updated by ECRI Institute on January 20, 2014.</p></div></p>
                        <h3><a href="#">Copyright Statement</a></h3>
                    <p><div class="content_para"><p>This NGC summary is based on the original full-text guideline, which is subject to the following copyright restrictions:</p>
<p>Copies of Cincinnati Children's Hospital Medical Center (CCHMC) Evidence-Based Clinical Practice Guidelines (EBCG) are available online and may be distributed by any organization for the global purpose of improving child health outcomes. Examples of approved uses of CCHMC's EBCG include the following:</p>
<ul style="list-style-type: disc;">
    <li>Copies may be provided to anyone involved in the organization's process for developing and implementing evidence-based care guidelines. </li>
    <li>Hyperlinks to the CCHMC website may be placed on the organization's website. </li>
    <li>The EBCG may be adopted or adapted for use within the organization, provided that CCHMC receives appropriate attribution on all written or electronic documents. </li>
    <li>Copies may be provided to patients and the clinicians who manage their care. </li>
</ul>
<p>Notification of CCHMC at <a href="https://web.archive.org/web/20180712182900/mailto:EBDMInfo@cchmc.org">EBDMInfo@cchmc.org</a> for any EBCG adopted, adapted, implemented or hyperlinked to by a given organization and/or user is appreciated.</p></div></p>

            </div>
                <h2 id="99999" class="accordion-title section-99999 is-active" role="tab" aria-expanded="true"><a href="#">Disclaimer</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">NGC Disclaimer</a></h3>
                    <p><p>The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href="/web/20180712182900/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria">NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p></p>

            </div>

    </div>
    <!-- /.accordion-container -->

<!-- ASIDE -->
<!-- FOOTER -->






		</div><!-- /.article -->

	</div><!-- /.content -->

	
			<div class="aside">
				

    <!-- About NGC -->
    <div class="info-block">
            <h3 class="info prefix-icon large-icon">About NGC Guideline Summaries</h3>
            <p>NGC provides structured summaries containing information from clinical practice guidelines.</p>
            <ul>
                <li><a href="/web/20180712182900/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria" class="internal-link">Inclusion Criteria</a></li>
                <li><a href="/web/20180712182900/https://www.guideline.gov/help-and-about/summaries/template-of-guideline-attributes" class="internal-link">Template of Guideline Attributes</a></li>
                <li><a href="/web/20180712182900/https://www.guideline.gov/help-and-about/summaries/classification-scheme" class="internal-link">Classification Scheme</a></li>
            </ul>
            <p><a href="/web/20180712182900/https://www.guideline.gov/help-and-about/summaries/faqs" class="help-button">Guideline Summary FAQs</a></p>

    </div>
    <!-- /info-block -->

    <!-- Guideline Synthesis -->

    <!-- HHS Block -->

    <!-- Related Content -->


    <hr>

    <!-- New on NGC -->
    <div class="subscribe-header">
        <h3 class="subscribe-title">New on NGC</h3>
        <ul class="subscribe-links">
            <li><a href="/web/20180712182900/https://www.guideline.gov/subscribe" class="newsletter"><span class="subscribe-links-label">Get Email Alerts</span></a></li>
            <li><a href="/web/20180712182900/https://www.guideline.gov/rssFiles/ngc_newthisweek.xml" class="rss"><span class="subscribe-links-label">RSS Feed</span></a></li>
        </ul>
    </div>
    <!-- /.subscribe-header -->
        <h5 class="prefix-icon guideline news-list-category-label">Guideline Summaries</h5>
        <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011378</li>
            <li>2017 Oct</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712182900/https://www.guideline.gov/summaries/summary/51300/mental-health-care-in-the-perinatal-period-australian-clinical-practice-guideline">Mental health care in the perinatal period: Australian clinical practice guideline.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011372</li>
            <li>2015</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712182900/https://www.guideline.gov/summaries/summary/51294/clinical-practice-guideline-on-systemic-lupus-erythematosus">Clinical practice guideline on systemic lupus erythematosus.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011385</li>
            <li>2018 Mar</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712182900/https://www.guideline.gov/summaries/summary/51326/vadod-clinical-practice-guideline-for-the-management-of-pregnancy">VA/DoD clinical practice guideline for the management of pregnancy.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011376</li>
            <li>2018 Feb</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712182900/https://www.guideline.gov/summaries/summary/51298/clinical-pharmacogenetics-implementation-consortium-cpic-guideline-for-dihydropyrimidine-dehydrogenase-genotype-and-fluoropyrimidine-dosing-2017-update">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011370</li>
            <li>2017 Dec</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712182900/https://www.guideline.gov/summaries/summary/51292/the-implementation-of-targeted-temperature-management-an-evidencebased-guideline-from-the-neurocritical-care-society">The implementation of targeted temperature management: an evidence-based guideline from the Neurocritical Care Society.</a></p>
    </div>

    <a class="block-link" href="/web/20180712182900/https://www.guideline.gov/new-this-week/index">
        <h3>New This Week </h3>
        <p>View more and sign up for our Newsletter</p>
    </a>
    <!-- Adobe Reader -->
    <p><a href="/web/20180712182900/https://www.guideline.gov/disclaimer?id=47380&amp;contentType=summary&amp;redirect=http%3A%2F%2Fget.adobe.com%2Freader%2F" class="external-link">Get Adobe Reader</a></p>

			</div><!-- /.aside -->
		</div><!-- /.aside-container -->

	<!-- BACK TO TOP -->
	
	
	



    <!-- COMMENTS -->
    

</div><!-- /.main -->

	</main>

	<!-- FOOTER -->
	<div class="footer" id="footer">

		<div class="footer-grid-container">
			<!-- Header -->
			<div class="footer-header">
				<a href="#" class="footer-logo">
			 		<picture>
					  	<source type="image/svg+xml" srcset="/web/20180712182900im_/https://www.guideline.gov/UI/images/logo_NGC_footer.svg">
					  	<img src="/web/20180712182900im_/https://www.guideline.gov/UI/images/logo_NGC_footer.png" alt="NGC">
					</picture>
				</a>
			</div><!-- /.footer-header -->

			<!-- Content -->
			<div class="footer-content">
				<div class="footer-nav">
					<ul class="level-1">
						<li><a href="/web/20180712182900/https://www.guideline.gov/">Home</a></li>
		                <li><a href="/web/20180712182900/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
						<li><a href="/web/20180712182900/https://www.guideline.gov/browse/organization" class="parent-link">Guideline Summaries</a></li>
<li><a href="/web/20180712182900/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>						<li><a href="/web/20180712182900/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		                <li><a href="/web/20180712182900/https://www.guideline.gov/matrix">Matrix Tool</a></li>
						<li><a href="/web/20180712182900/https://www.guideline.gov/summaries/submit">Submit Guidelines</a></li>
						<li><a href="/web/20180712182900/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>
					</ul>
					<ul class="level-2">
						<li><a href="/web/20180712182900/https://www.guideline.gov/contact-us">Contact Us</a></li>
						<li><a href="/web/20180712182900/https://www.guideline.gov/rss">RSS</a></li>
					    <li><a href="/web/20180712182900/https://www.guideline.gov/site-map">Site Map</a></li>
                        <li><a href="/web/20180712182900/https://www.guideline.gov/browse/related">Related NQMC Measures</a></li>
                        <li><a href="/web/20180712182900/https://www.guideline.gov/help-and-about/about/editorial-board">Editorial Board</a></li>
                        <li><a href="/web/20180712182900/https://www.guideline.gov/help-and-about/general/web-site-credits">Web Site Credits</a></li>
                        <li><a href="/web/20180712182900/https://www.guideline.gov/help-and-about/general/disclaimer">Disclaimer</a></li>
						<li><a href="/web/20180712182900/https://www.guideline.gov/help-and-about/general/privacy">Privacy Policy</a></li>
                        <li><a href="/web/20180712182900/https://www.guideline.gov/help-and-about/technical/accessibility">Accessibility</a></li>	
                        <li><a href="/web/20180712182900/https://www.guideline.gov/help-and-about/technical/for-web-developers">For Web Developers</a></li>
					</ul>
				</div><!-- /.footer-nav -->
			</div><!-- /.footer-content -->

			<!-- Aside -->
			<div class="footer-aside">
				<h5 class="footer-partner-link-header">Visit our partner sites</h5>
				<ul class="footer-partner-links">
				    <li><!-- NQMC footer link -->
						<a href="https://web.archive.org/web/20180712182900/https://www.qualitymeasures.ahrq.gov/" target="_blank" class="partner-button nqmc">
							<span class="partner-logo">
								<picture>
							    	<source type="image/svg+xml" srcset="/web/20180712182900im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.svg">
									<img src="/web/20180712182900im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.png" alt="National Quality Measures Clearinghouse"/>
								</picture>
							</span>
						</a>
					</li><!--/MQMC footer Link -->
					<li><!-- HHS footer link --> 
						<a href="https://web.archive.org/web/20180712182900/https://www.qualitymeasures.ahrq.gov/hhs/index.aspx" target="_blank" class="partner-button hhs">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180712182900im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.svg">
								    <img src="/web/20180712182900im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.png" alt="HHS Measures Inventory"/>
								</picture>
							</span>
						</a>
					</li><!--/HHS footer link -->
				</ul>
			</div><!-- /.footer-aside -->

		</div><!-- /.footer-grid-container -->

	</div><!-- /.footer -->

	
	<!-- AHRQ FOOTER -->
	<div id="ahrq-footer">

		<!-- FIRST -->
		<div class="ahrq-first-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<p><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/index.html" class="ahrq-footer-logo" target="_blank">AHRQ</a></p>
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/policy/electronic/accessibility/index.html" target="_blank">Accessibility</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/policy/electronic/disclaimers/index.html" target="_blank">Disclaimers</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/policy/eeo/index.html" target="_blank">EEO</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/policy/foia/index.html" target="_blank">FOIA</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.hhs.gov/web/governance/digital-strategy/index.html" target="_blank">HHS Digital Strategy</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://oig.hhs.gov/" target="_blank">Inspector General</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/policy/electronic/plain-writing/index.html" target="_blank">Plain Writing Act</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/policy/electronic/privacy/index.html" target="_blank">Privacy Policy</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/policy/electronic/about/policyix.html" target="_blank">Electronic Policies</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.hhs.gov/plugins.html" target="_blank">Viewers &amp; Players</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<h3>Get Social</h3>
					<ul class="ahrq-social">
						<li><a href="https://web.archive.org/web/20180712182900/http://www.facebook.com/" target="_blank" class="facebook"><span class="screen-reader-text">Facebook</span></a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.twitter.com/" target="_blank" class="twitter"><span class="screen-reader-text">Twitter</span></a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.linkedin.com/" target="_blank" class="linkedin"><span class="screen-reader-text">LinkedIn</span></a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.youtube.com/" target="_blank" class="youtube"><span class="screen-reader-text">YouTube</span></a></li>
					</ul>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.first-footer -->

		<!-- SECOND -->
		<div class="ahrq-second-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<ul>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/index.html" target="_blank" class="ahrq-footer-home-link"><span class="screen-reader-text">AHRQ Home</span></a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/cpi/about/index.html" target="_blank">About Us</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/cpi/about/careers/index.html" target="_blank">Careers</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/contact/index.html" target="_blank">Contact Us</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/Sitemap.html" target="_blank">Sitemap</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/https://info.ahrq.gov/" target="_blank">FAQ</a></li>
					</ul>	
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/health-care-information/index.html" target="_blank">Health Care Information</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/patients-consumers/index.html" target="_blank">For Patients &amp; Consumers</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/professionals/index.html" target="_blank">For Professionals</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/policymakers/index.html" target="_blank">For Policymakers</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/research/index.html" target="_blank">Research Tools &amp; Data</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/funding/index.html" target="_blank">Funding &amp; Grants</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/cpi/index.html" target="_blank">Offices, Centers &amp; Programs</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.ahrq.gov/news/index.html" target="_blank">News &amp; Events</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<ul>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.hhs.gov/" target="_blank">U.S. Department of Health &amp; Human Services</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.whitehouse.gov/" target="_blank">The White House</a></li>
						<li><a href="https://web.archive.org/web/20180712182900/http://www.usa.gov/" target="_blank">USA.gov: The U.S. Government's Official Web Portal   </a></li>
					</ul>
					<p class="ahrq-address">
						<strong>Agency for Healthcare Research&nbsp;and&nbsp;Quality</strong>
					    <br/>5600 Fishers Lane
					    <br/>Rockville, MD 20857
					    <br/><strong>Telephone:</strong> (301) 427-1364
					</p>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.second-footer -->
	</div><!-- /#ahrq-footer -->


	
	<!-- SCRIPTS -->
	
<script src="//web.archive.org/web/20180712182900js_/https://ajax.googleapis.com/ajax/libs/jquery/1.6.3/jquery.min.js" type="text/javascript"></script>
<script type="text/javascript">
if(!window.jQuery){
document.write('<script src="/cassette.axd/script/cdd67f922f9d413eaccb759182297335f87c3ff7/UI/js/jquery.js" type="text/javascript"><\/script>');
}
</script>
<script src="/web/20180712182900js_/https://www.guideline.gov/cassette.axd/script/595952c286b7fd52f0737b6f62085709be93156a/bodyJS" type="text/javascript"></script>

    
</body>
</html>
<!--
     FILE ARCHIVED ON 18:29:00 Jul 12, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 17:18:52 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 95.467 (3)
  esindex: 0.006
  captures_list: 115.785
  CDXLines.iter: 15.48 (3)
  PetaboxLoader3.datanode: 79.309 (4)
  exclusion.robots: 0.236
  exclusion.robots.policy: 0.222
  RedisCDXSource: 0.683
  load_resource: 44.628
-->